Yes. The following templates can be used when citing material from RxVigilance.
For RxVigilance in general
RxVigilance Version February 2024 [Software]. Repentigny (Quebec): Vigilance Santé Inc. [cited 2024 Mar 09]
For a particular section in RxVigilance
Monographs: Atorvastatin (Monographs). In: RxVigilance Version February 2024 [Software]. Repentigny (Quebec): Vigilance Santé Inc. [cited 2024 Mar 09]
Comparative Drug Charts: Drugs used to treat hypertension (Comparative Drug Charts). In: RxVigilance Version February 2024 [Software]. Repentigny (Quebec): Vigilance Santé Inc. [cited 2024 Mar 09]
Compounding Formulas: Amlodipine 1 mg/mL oral suspension (Compounding Formulas). In: RxVigilance Version February 2024 [Software]. Repentigny (Quebec): Vigilance Santé Inc. [cited 2024 Mar 09]
In respect of copyright, the information quoted should not represent a substantial or important part of the software.
Also, note that Vigilance Santé is not liable for any errors, omissions, losses or damages arising out of or in connection with the use (or misuse) of the information, or any conclusions contained in or deduced from the information contained in the tool.